Devvrat Yadav, MD joined the Division of Hospital Medicine in the Department of Internal Medicine as an Instructor in July 2025. He completed his medical school from the All India Institute of Medical Sciences (AIIMS), New Delhi, the most prestigious medical institute in India. Following medical school, Yadav completed a two-year Postdoctoral Research Fellowship in the Division of Gastroenterology and Hepatology at Mayo Clinic School of Medicine in Rochester, Minnesota. He went on to complete his Internal Medicine residency at Sinai Hospital of Baltimore, Maryland. During residency, he continued to explore the role of the gut microbiome, with a particular focus on gastrointestinal cancers and CAR T-cell therapy. Yadav’s academic passions include medical education, clinical research, and mentoring. He is particularly interested in bedside physical examination, high-value care, and delivering efficient, patient-centered treatment in the inpatient setting.
Education
- MBBS: All India Institute of Medical Sciences, New Delhi, India (2019)
- Residency, Internal Medicine: Sinai Hospital of Baltimore, Baltimore, MD (2025)
Clinical Interests
Gut microbiome, gastrointestinal cancers, CAR T-cell therapy, medical education, clinical research
Publications
Sainatham C., Yadav D., Babu A., Fillipov E., Kanagala G., Murillo F., Lutfi F. The Scientific, Socioeconomic, and Regulatory Landscape of Immune Effector Cell Therapies (in-process)
Jayakrishnan T., Yadav D., Huffman B., Cleary J. Immunological Checkpoint Blockade in Anal Squamous Cell Carcinoma: Dramatic Responses Tempered by Frequent Resistance. June, 2024 DOI: 10.1007/s11912-024-01564-z
Yadav D., Sainatham C., Filippov E., Kanagala SG., Ishaq SM, Jayakrishnan, T. Gut Microbiome and Colorectal Cancer Relationship 2024. DOI: https://doi.org/10.3390/microorganisms12030484
Yadav D., Sainatham, C., Verma, S., Anisha G., Vinayek R. Unintended Discovery of Duodenal Gangliocytic Paraganglioma in a Patient with Chronic Graft-vs-Host Disease. American College of Gastroenterology 2023
Yadav D., Kaushik S., Singh A., Curin M. Safety and Efficacy of Hemorrhoid Energy Therapy: Systematic Review and Meta-Analysis. American College of Gastroenterology 2023
Yadav D., Dierkhising R., Khanna S., Sweetser S. Reappraisal of the Population-Based Incidence of Colonic Ischemia. American College of Gastroenterology 2023.
Yadav D., Sathi T., Khanna S., Sweetser S. The Association Between Medications and Outcomes for Colonic Ischemia. Gastroenterology 2022
Shivabalan KR., Byale A., Ajith K, Yadav D., Mishra R., Gautam M. Thermodynamic Indices of Brain Activity to Identify People with Good Cognitive Capacity (P4-6.002). Neurology 2022.
Sehgal K., Yadav D., Khanna S. The Interplay of Clostridioides difficile Infection and Inflammatory Bowel Disease. Therapeutic Advances in Gastroenterology 2021 DOI: 10.1177/17562848211020285
Tariq R., Yadav D., Sehgal K., Pardi D.S. and Khanna S. Efficacy of Saccharomyces boulardii for Prevention of Clostridioides difficile infection: A Systematic Review and Meta-Analysis. The American Journal of Gastroenterology 2021 116(1):S59-S60
Tariq R., Syed T., Yadav D., Prokop L., Singh S., Loftus E., Pardi D., Khanna S. Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Metaanalysis. Journal of Clinical Gastroenterology 2021 DOI: 10.1097/MCG.0000000000001633
Yadav D., Saha, S., Pardi, R., Pardi, D., Khanna, S. Evaluation Of Body Mass Index And Neuropsychiatric Diseases in Offspring Born to Mothers with Peripartum Clostridioides difficile Infection. Gastroenterology, 2021 160(6), S-384
Saha S., Yadav D., Pardi R., Patel R., Khanna S., Pardi D. Kinetics of Polymerase Chain Reaction Positivity in Patients with Clostridioides difficile Infection. Therapeutic Advances in Gastroenterology 2021
Yadav D., Khanna S. (2021, Apr). Safety of Fecal Microbiota Transplantation for Clostridioides difficile Infection Focusing on Pathobionts and SARS-CoV-2. Therapeutic Advances in Gastroenterology 2021
Yadav D., Pardi D., Khanna S. Effect of Vancomycin on Primary Sclerosing Cholangitis in Patients with Clostridioides difficile Infection. American College of Gastroenterology 2021 116, S1393.